Diabetic foot disease, mainly due to neuropathy, peripheral arterial disease (PAD), and/or infection, often leads to ulceration and possible subsequent limb amputation. It is one of the most costly complications of diabetes.
CLTI is a more severe form of PAD with significant mortality, morbidity and higher use of health care resources1Conte MS, Bradbury AW, Kolh P, et. al, Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006., 2 Featuring PeriFlux 6000 Combined System. (2020, May 12). Retrieved November 19, 2020, from https://dreambroker.com/channel/a0tack52/z7e8lwug. The distal blood flow and microcirculatory function are severely compromised resulting in rest pain, ischemic ulcers and gangrene. CLTI is a clinical diagnosis but should be supported by objective vascular testing. Due to the high risk of calcified vessels with falsely normal or high ABI, even in non-diabetics, toe pressures, PVR and tcpO2 must be used in all patients.
30% of all patients with confirmed CLTI have normal or high ABI.
All patients with suspected CLTI should have toe pressure or tcpO2 to assess perfusion according to WIfI classification3Mills JL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2014;59(1):220034.e1-2..
The best modality to grade the level of ischemia and prioritize vascular procedures is tcpO2.
Due to the complex nature of CLTI, all patients that undergo vascular intervention should be reassessed with toe pressure or tcpO2 to guarantee restored perfusion.
All-in-one simultaneous Assessment
The PeriFlux 6000 Combined System offers the unique capability to simultaneously assess both Toe Pressure and PVR as well as measure Transcutaneous Oxygen in the tissue with one system saving limbs, lives, cost and reducing human suffering.
User-friendly software is guiding the user throughout the examination with a standardized measurement procedure for reliable and reproducible results.
A comprehensive report is instantly generated with all clinical information clearly stated with curves adding clarity. The report, as well as the workflow, can be customized to suit processes in clinical situations worldwide.
Perfusion imaging for PAD and diabetic foot ulcers
Perimed was the first company to commercialize laser-based microcirculation imaging and has over the past 40 years been the world leader in perfecting those techniques.
The PeriCam PSI provides a fast and accurate way to assess microcirculation in tissue by using laser speckle contrast analysis (LASCA or LSCI). It fits into the growing demand for non-invasive imaging techniques in diagnostics. All major guidelines [ref 1,2,3] on diagnosis and management of PAD and diabetic foot ulcers recognize the need for microcirculation assessment. The International Working Group on the Diabetic Foot (IWGDF) also highlights the need to investigate the role of novel methods of perfusion assessment [ref 3].
Recent expert reviews mentioned LSCI as a possible diagnostic technique to determine tissue perfusion in patients with PAD [ref 4] and/or diabetic foot ulcers [ref 5] and PeriCam PSI has shown to be a promising tool in these assessments [ref 6,7]. It can offer several advantages compared to other diagnostic techniques:
No contact with patient needed
No need for injectable contrast agents
No ionizing radiation
Ease of use
Intuitive and powerful software for measurement setup, recording and analysis
Small format system offers great flexibility in busy and crowded environments
Easy to position due to flexible arm and ball head mount.
Real time imaging: up to ~100 images per second
The Pericam PSI Imaging system is clinically approved for measurement of microcirculation in the USA, Europe, China and many other markets.
Conte MS, Bradbury AW, Kolh P, et. al, Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006.
Mills JL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2014;59(1):220034.e1-2. DOI: 10.1016/j.jvs.2013.08.003
Hinchliffe et al. Guideline on diagnosis, prognosis and management of peripheral artery disease among people with diabetes (IWGDF 2019 update). Diab Metab Res Rev. 2020. e3276 DOI: 10.1002/dmrr.3276
Kirsten F. Ma, Simone F. Kleiss, Richte C.L. Schuurmann, Reinoud P.H. Bokkers, Çagdas Ünlü & Jean-Paul P.M. De Vries (2019) A systematic review of diagnostic techniques to determine tissue perfusion in patients with peripheral arterial disease, Expert Review of Medical Devices, 16:8, 697-710, DOI: 10.1080/17434440.2019.1644166
Onno A. Mennes, Jaap J. van Netten, Riemer H.J.A. Slart and Wiendelt Steenbergen, “Novel Optical Techniques for Imaging Microcirculation in the Diabetic Foot”, Current Pharmaceutical Design (2018) 24: 1304. DOI: 10.2174/1381612824666180302141902
Anne Humeau-Heurtier, Pierre Abraham, Samir Henni, Bi-dimensional variational mode decomposition of laser speckle contrast imaging data: A clinical approach to critical limb ischemia?, Computers in Biology and Medicine 86, 2017, 107-112 DOI: 10.1016/j.compbiomed.2017.05.012
A. Mennes, J.J. van Netten, J.G. van Baal, W. Steenbergen, Assessment of microcirculation in the diabetic foot with laser speckle contrast imaging, Physiological Measurement 40 065002 DOI: 10.1088/1361-6579/ab2058